Andrew M. McIntosh

Andrew M. McIntosh is a UK academic psychiatrist. He is Professor of Biological Psychiatry at the University of Edinburgh,.^[1][2] The main focus of his research is using genomic and neuroimaging approaches to better understand the causes and causal consequences of Major Depressive Disorder.^[3]

Andrew M. McIntosh FRCPsych FRSE FMedSci
Born	Aberdeen
Alma mater	University of Aberdeen University of Edinburgh
Scientific career
Fields	Biological Psychiatry Genomics Data Science

Education

He completed his undergraduate medical training MBChB at the University of Aberdeen and psychiatric training in Scotland at the Royal Edinburgh Hospital, before gaining MRCPsych in 2000.^[4] He has an MPhil (Psychiatry) and MD (Psychiatry, 2004) from the University of Edinburgh and a MSc in Applied Statistics.^{[citation needed]} He has held MRC Clinical Training, Health Foundation/Academy of Medical Sciences Clinician Scientist and Scottish Funding Council Senior Clinical Fellowships.^[4]

Career

McIntosh is Director of the UK Research and Innovation (UKRI) Mental Health Platform and co-chair of the Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium^[5] with Cathryn Lewis. He is Chief Scientist of the Health Data Research UK Mental Health Hub^[6] and chair of the Generation Scotland Mental Health Expert Working Group and was founding Chair of the MQ Mental Health Data Science Group.^[7] McIntosh is a Wellcome Trust Investigator and is an investigator on many studies of depression, including DepGenAfrica.^[8]

Selected publications

• McIntosh, AM (2019). "Uncovering the Genetic Architecture of Major Depression". Neuron. 102 (1): 91–103. doi:10.1016/j.neuron.2019.03.022. PMC 6482287. PMID 30946830.

External links

• Bawden, Anna (14 January 2025). "Scientists find hundreds more genetic risk factors for depression". The Guardian. Retrieved 21 February 2025. Prof Andrew McIntosh from the University of Edinburgh's Centre for Clinical Brain Sciences, said: "There are huge gaps in our understanding of clinical depression that limit opportunities to improve outcomes for those affected."